The financial dialogue in investment circles frequently revolves around the quest for undervalued sectors poised for growth. Recently, one area drawing attention is the biopharmaceutical industry, particularly the larger companies within this domain, such as Merck, Pfizer, Bristol Myers Squibb, Amgen, and Biogen. A contrasting nuance exists with notable players like Eli Lilly and Novo
Investing
Warren Buffett, often revered as one of the greatest investors of all time, is synonymous with the buy-and-hold investment strategy. His preferences are clear: he thrives on long-term holdings, believing that the best time to sell is almost never. However, when he does divest, it raises eyebrows across the financial landscape and evokes concern about